David Windley
Stock Analyst at Jefferies
(3.65)
# 723
Out of 4,832 analysts
189
Total ratings
66.06%
Success rate
13.6%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNC Centene | Maintains: Hold | $64 → $61 | $59.82 | +1.97% | 28 | Apr 29, 2025 | |
| OSCR Oscar Health | Initiates: Underperform | $12 | $16.23 | -26.06% | 1 | Dec 10, 2024 | |
| HUM Humana | Downgrades: Hold | $419 → $253 | $229.97 | +10.01% | 18 | Oct 7, 2024 | |
| FTRE Fortrea Holdings | Downgrades: Hold | $25 → $21 | $4.58 | +359.02% | 2 | Sep 25, 2024 | |
| MEDP Medpace Holdings | Downgrades: Hold | $415 → $345 | $293.24 | +17.65% | 5 | Sep 25, 2024 | |
| CI The Cigna Group | Maintains: Buy | $402 → $422 | $303.88 | +38.87% | 17 | Sep 17, 2024 | |
| MOH Molina Healthcare | Maintains: Hold | $354 → $297 | $312.48 | -4.95% | 23 | Jul 24, 2024 | |
| IQV IQVIA Holdings | Downgrades: Hold | $266 → $242 | $145.28 | +66.57% | 4 | Jul 24, 2024 | |
| UNH UnitedHealth Group | Upgrades: Buy | $481 → $647 | $312.97 | +106.73% | 26 | Jul 17, 2024 | |
| NOTV Inotiv | Downgrades: Hold | $12 → $3.75 | $2.02 | +85.64% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $602 → $604 | $380.25 | +58.84% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $365 → $375 | $562.32 | -33.31% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $16 | $12.92 | +20.02% | 3 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $238.51 | +13.20% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $16 | $11.65 | +33.10% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $323 → $536 | $210.59 | +154.53% | 10 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $39 → $29 | $23.76 | +22.05% | 2 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $233 → $203 | $140.00 | +45.00% | 19 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $276 → $302 | $134.34 | +124.80% | 14 | Sep 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $264 → $248 | $7.43 | +3,240.07% | 1 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.56 | - | 5 | Oct 9, 2017 |
Centene
Apr 29, 2025
Maintains: Hold
Price Target: $64 → $61
Current: $59.82
Upside: +1.97%
Oscar Health
Dec 10, 2024
Initiates: Underperform
Price Target: $12
Current: $16.23
Upside: -26.06%
Humana
Oct 7, 2024
Downgrades: Hold
Price Target: $419 → $253
Current: $229.97
Upside: +10.01%
Fortrea Holdings
Sep 25, 2024
Downgrades: Hold
Price Target: $25 → $21
Current: $4.58
Upside: +359.02%
Medpace Holdings
Sep 25, 2024
Downgrades: Hold
Price Target: $415 → $345
Current: $293.24
Upside: +17.65%
The Cigna Group
Sep 17, 2024
Maintains: Buy
Price Target: $402 → $422
Current: $303.88
Upside: +38.87%
Molina Healthcare
Jul 24, 2024
Maintains: Hold
Price Target: $354 → $297
Current: $312.48
Upside: -4.95%
IQVIA Holdings
Jul 24, 2024
Downgrades: Hold
Price Target: $266 → $242
Current: $145.28
Upside: +66.57%
UnitedHealth Group
Jul 17, 2024
Upgrades: Buy
Price Target: $481 → $647
Current: $312.97
Upside: +106.73%
Inotiv
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $2.02
Upside: +85.64%
Apr 19, 2024
Maintains: Buy
Price Target: $602 → $604
Current: $380.25
Upside: +58.84%
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $562.32
Upside: -33.31%
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $12.92
Upside: +20.02%
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $238.51
Upside: +13.20%
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $11.65
Upside: +33.10%
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $210.59
Upside: +154.53%
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $23.76
Upside: +22.05%
Mar 28, 2023
Maintains: Hold
Price Target: $233 → $203
Current: $140.00
Upside: +45.00%
Sep 14, 2021
Maintains: Buy
Price Target: $276 → $302
Current: $134.34
Upside: +124.80%
Feb 25, 2021
Maintains: Hold
Price Target: $264 → $248
Current: $7.43
Upside: +3,240.07%
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.56
Upside: -